Skip to main navigation Skip to search Skip to main content

Retraction notice to "Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?" (Biomedicine & Pharmacotherapy, (2022), 154, C, (113522), (S0753332222009118), 10.1016/j.biopha.2022.113522)

  • Manish Dhawan
  • , Abdul Rahman A. Saied
  • , Saikat Mitra
  • , Fahad A. Alhumaydhi
  • , Talha Bin Emran
  • , Polrat Wilairatana
  • Punjab Agricultural University
  • Altrincham
  • National Food Safety Authority (NFSA)
  • Ministry of Tourism and Antiquities
  • University of Dhaka
  • Qassim University
  • BGC Trust University Bangladesh
  • Daffodil International University

Research output: Contribution to journal › Comment/debate

Abstract

This article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal). This article has been retracted at the request of the Editor. An investigation conducted on behalf of the journal by Elsevier's Research Integrity & Publishing Ethics team found that 12 citations were added to this paper at the author proof stage, without the approval of the Editor. The new citations were not immediately relevant to the topic of the paper and benefit authors, Talha Bin Emran and Manish Dhawan. The Editor has lost confidence in the results and conclusions of the article and has determined it should be retracted. The corresponding author did not respond to the retraction notice.

Original languageEnglish
Article number119215
JournalBiomedicine and Pharmacotherapy
Volume197
DOIs
Publication statusPublished - Apr 2026

Fingerprint

Dive into the research topics of 'Retraction notice to "Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?" (Biomedicine & Pharmacotherapy, (2022), 154, C, (113522), (S0753332222009118), 10.1016/j.biopha.2022.113522)'. Together they form a unique fingerprint.

Cite this